Chronic hyperaldosteronism in a transgenic mouse model fails to induce hypertension and cardiac hypertrophy

被引：0
|
作者：
Wang, Q
Clement, S
Gabbiani, G
Horisberger, JD
Rossier, BC
Burnier, M
Hummler, E
机构：
[1] Univ Lausanne Hosp, Div Hypertens, Lausanne, Switzerland
[2] Univ Hosp Geneva, Dept Pathol, Geneva, Switzerland
[3] Univ Lausanne, Inst Pharmacol, Lausanne, Switzerland
来源：
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2003年 / 14卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：136A / 136A
页数：1
相关论文
共 50 条
  • [31] An Angiotensin II Type I Receptor Mutant Ameliorates The Hypertension And Cardiac Hypertrophy Caused By Chronic Angiotensin II Infusion in Transgenic Mice
    Ahmed, Saad
    Cesana, Francesca
    Gavras, Haralambos
    Yu, Jun
    CIRCULATION, 2008, 118 (18) : S275 - S276
  • [32] Cardiac-specific overexpression of mouse cardiac calsequestrin is associated with depressed cardiovascular function and hypertrophy in transgenic mice
    Sato, Y
    Ferguson, DG
    Sako, H
    Dorn, GW
    Kadambi, VJ
    Yatani, A
    Hoit, BD
    Walsh, RA
    Kranias, EG
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (43) : 28470 - 28477
  • [33] The Role of Integrins in the Regulation of Vascular Hypertrophy in a Profilin 1 Transgenic Mouse Model
    Abouelnaga, Zeinb Ahmed
    Hassona, Mohamed Darwish Hessein
    Abdulrahman, Basant
    Elnakish, Mohammad
    Hassanain, Hamdy
    FASEB JOURNAL, 2010, 24
  • [34] DOCA salt hypertension in ACE knockout transgenic mice: Influence of genotype on cardiac hypertrophy and function
    Perry, GJ
    Tian, BH
    Chen, YF
    Meng, QC
    Krege, J
    Oparil, S
    CIRCULATION, 1996, 94 (08) : 3869 - 3869
  • [35] Prevention of cardiac hypertrophy by atorvastatin in a transgenic rabbit model of human hypertrophic cardiomyopathy
    Senthil, V
    Chen, SN
    Nagueh, SF
    Willerson, JT
    Roberts, R
    Marian, AJ
    CIRCULATION, 2005, 112 (17) : U244 - U244
  • [36] Prevention of cardiac hypertrophy by atorvastatin in a transgenic rabbit model of human hypertrophic cardiomyopathy
    Senthil, V
    Chen, SN
    Tsybouleva, N
    Halder, T
    Nagueh, SF
    Willerson, JT
    Roberts, R
    Marian, AJ
    CIRCULATION RESEARCH, 2005, 97 (03) : 285 - 292
  • [37] Concentric cardiac remodeling and hypertrophy as predictors of superimposed preeclampsia in women with chronic hypertension
    Seagraves, Elizabeth
    Barake, Carole
    Baraki, Dana
    Donaldson, Thomas
    Abuhamad, Alfred
    Kawakita, Tetsuya
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2022, 226 (01) : S444 - S444
  • [38] Hypertension, cardiac hypertrophy, and neurohumoral activity in a new animal model of obesity
    Carroll, JF
    Dwyer, TM
    Grady, AW
    Reinhart, GA
    Montani, JP
    Cockrell, K
    Meydrech, EF
    Mizelle, HL
    AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 1996, 271 (01): : H373 - H378
  • [39] Effects of hypertension and different therapies on cardiac hypertrophy and fibrosis in a RAT model
    Ziegelhöffer-Mihalovi ová, B
    Rassler, B
    Tannapfel, A
    Zimmer, HG
    JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2005, 38 (06) : 1059 - 1059
  • [40] Sensory ataxia and cardiac hypertrophy caused by neurovascular oxidative stress in chemogenetic transgenic mouse lines
    Yadav, Shambhu
    Waldeck-Weiermair, Markus
    Spyropoulos, Fotios
    Bronson, Roderick
    Pandey, Arvind K.
    Das, Apabrita Ayan
    Sisti, Alexander C.
    Covington, Taylor A.
    Thulabandu, Venkata
    Caplan, Shari
    Chutkow, William
    Steinhorn, Benjamin
    Michel, Thomas
    NATURE COMMUNICATIONS, 2023, 14 (01)
12345